Literature DB >> 6467674

Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.

M Castés, A Agnelli, A J Rondón.   

Abstract

Mechanisms possibly involved in the regulation of the immune response were evaluated in 49 patients with American cutaneous leishmaniasis (ACL). The patients were classified on the basis of clinical and histopathological criteria as suffering localized (LCL), mucocutaneous (MCL) or diffuse (DCL) forms of the disease. A significant leishmanial antigen-induced suppression of in vitro mitogen responsiveness was demonstrated in the DCL group, but not in the other two diseases states. Lack of suppressive activity was particularly evident in MCL, this being the group that presented the highest in vivo and in vitro reactivity to the parasite antigens. In fact, a significant inverse correlation was found between the degree of suppression and the antigen-induced lymphocyte proliferative response. In contrast, a mixture of mononuclear cells from MCL patients and normal subjects showed higher that expected responses to mitogen, while this increase was not observed in co-cultures of DCL and normal mononuclear cells. Due to their possible modulatory influences, circulating immune complexes were also evaluated in these patient groups, higher levels being found in MCL and DCL patients than in either LCL or controls. The possible mechanisms involved in the regulation of the immune response to the protozoan in the complex disease spectrum of ACL are discussed in relation to anergy in DCL and hyperresponsiveness in MCL.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467674      PMCID: PMC1536102     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Evidence for circulating immune complexes in lepromatous leprosy.

Authors:  C J Moran; G Ryder; J L Turk; M F Waters
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

2.  The Kellersberger Memorial Lecture: leprosy and leishmaniasis similar clinical-immunological-pathological models.

Authors:  J Convit
Journal:  Ethiop Med J       Date:  1974-10

3.  Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host.

Authors:  J Convit; M E Pinardi; A J Rondón
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

4.  Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.

Authors:  F Y Liew; C Hale; J G Howard
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

5.  Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis.

Authors:  E A Petersen; F A Neva; C N Oster; H Bogaert Diaz
Journal:  N Engl J Med       Date:  1982-02-18       Impact factor: 91.245

Review 6.  Detection of immune complexes in human diseases.

Authors:  R H Zubler; P H Lambert
Journal:  Prog Allergy       Date:  1978

7.  Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse.

Authors:  P M Preston; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

8.  Factors influencing the host response to Leishmania mexicana.

Authors:  H Pérez
Journal:  Ciba Found Symp       Date:  1983

9.  Characterization of the cellular immune response in American cutaneous leishmaniasis.

Authors:  M Castes; A Agnelli; O Verde; A J Rondón
Journal:  Clin Immunol Immunopathol       Date:  1983-05

10.  [Immunological aspects of Leishmania that parasite man, with special reference to Leishmania brasiliensis pifanoi, Medina & Romero, 1957].

Authors:  F PIFANO; J V SCORZA
Journal:  Arch Venez Med Trop Parasitol Med       Date:  1960-12
View more
  16 in total

1.  Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression.

Authors:  A C Maretti-Mira; M P de Oliveira-Neto; A M Da-Cruz; M P de Oliveira; N Craft; C Pirmez
Journal:  Clin Exp Immunol       Date:  2010-11-22       Impact factor: 4.330

2.  Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.

Authors:  Daniela R Faria; Kenneth J Gollob; José Barbosa; Albert Schriefer; Paulo R L Machado; Hélio Lessa; Lucas P Carvalho; Marco Aurélio Romano-Silva; Amélia R de Jesus; Edgar M Carvalho; Walderez O Dutra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis.

Authors:  F Conceição-Silva; R C Dórea; C Pirmez; A Schubach; S G Coutinho
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

4.  Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Authors:  Olívia Bacellar; Hélio Lessa; Albert Schriefer; Paulo Machado; Amélia Ribeiro de Jesus; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Identification of antigens recognized by T cells in human leishmaniasis: analysis of T-cell clones by immunoblotting.

Authors:  P C Melby; D L Sacks
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in American cutaneous leishmaniasis patients.

Authors:  M Castes; D Trujillo; D Scott; A J Rondon
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

Review 7.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

8.  Human american cutaneous leishmaniasis (Leishmania b. braziliensis) in Brazil: lymphoproliferative responses and influence of therapy.

Authors:  S C Mendonça; S G Coutinho; R R Amendoeira; M C Marzochi; C Pirmez
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

9.  T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis.

Authors:  M Castes; M Cabrera; D Trujillo; J Convit
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

10.  Cytokine patterns in the pathogenesis of human leishmaniasis.

Authors:  C Pirmez; M Yamamura; K Uyemura; M Paes-Oliveira; F Conceição-Silva; R L Modlin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.